| Efficacy of anti-HER2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced HER2-positive breast cancer patients: a network meta-analysis M Debiasi, CA Polanczyk, P Ziegelmann, C Barrios, H Cao, JJ Dignam, ... Frontiers in Oncology 8, 156, 2018 | 36 | 2018 |
| The management of immune-related adverse events associated with immune checkpoint blockade AP Fay, RB Moreira, PRS Nunes Filho, C Albuquerque, CH Barrios Expert Review of Quality of Life in Cancer Care 1 (1), 89-97, 2016 | 22 | 2016 |
| Vitamin D deficiency in pediatric patients using antiepileptic drugs: systematic review with meta-analysis C Junges, TD Machado, PRS Nunes Filho, R Riesgo, ED Mello Jornal de Pediatria 96, 559-568, 2020 | 20 | 2020 |
| Locally advanced breast cancer in Brazil: current status and future perspectives G Werutsky, P Nunes, C Barrios ecancermedicalscience 13, 2019 | 15 | 2019 |
| The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non … G Werutsky, FC Maluf, EH Cronemberger, V Carrera Souza, ... BMC cancer 19, 1-8, 2019 | 13 | 2019 |
| Updated analysis of global epidemiology of EGFR mutation in advanced non-small cell lung cancer: track: prevention, early detection, epidemiology and tobacco control G Werutsky, M Debiasi, FH Sampaio, PR Nunes Filho, C Mathias, M Zukin, ... Journal of Thoracic Oncology 11 (10), S184-S185, 2016 | 13 | 2016 |
| Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non–Small-Cell Lung Cancer ACZ Gelatti, VCC de Lima, H Freitas, G Werutsky, AM Gaiger, C Klock, ... Clinical Lung Cancer 21 (6), e511-e515, 2020 | 12 | 2020 |
| Immune checkpoint inhibitors in breast cancer: a narrative review P Nunes Filho, C Albuquerque, M Pilon Capella, M Debiasi Oncology and Therapy 11 (2), 171-183, 2023 | 8 | 2023 |
| Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+ APA in patients with advanced prostate cancer … FC Maluf, AP Fay, VC Souza, FAB Schutz, O Smaletz, D Herchenhorn, ... Journal of Clinical Oncology 38 (15_suppl), 5505-5505, 2020 | 8 | 2020 |
| Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215) AN Rodrigues, AC de Melo, AF de Carvalho Calabrich, E Cronenberger, ... International Journal of Gynecologic Cancer 32 (2), 2022 | 7 | 2022 |
| Global epidemiology of EGFR mutation in advanced non-small cell lung cancer G Werutsky, M Debiasi, FHD Sampaio, PRS Nunes Filho, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S585-S586, 2015 | 4 | 2015 |
| Influence of physician’s lifestyle on the prescription of healthy habits to breast cancer patients (LACOG 1218) R Cangussú, E Mascarenhas, TF Rebelatto, F Zaffaroni, RG de Jesus, ... Supportive Care in Cancer 30 (5), 4399-4406, 2022 | 2 | 2022 |
| Association of age, race, and public health insurance with stage of cervical cancer at diagnosis in Brazil: Results of the EVITA cohort study (LACOG0215). AN Rodrigues, AC de Melo, A Calabrich, E Cronemberger, KL Torres, ... Journal of Clinical Oncology 36 (15_suppl), e17509-e17509, 2018 | 2 | 2018 |
| Imunização nos pacientes em tratamento oncológico E Ammar, R Furian, RP Saadi, PCF Crivelaro, PRS Nunes Filho Acta méd.(Porto Alegre), 173-181, 2018 | 1 | 2018 |
| Marcas nos corpos: em foco o HIV/AIDS ALC Costa, RP Quadrado, PRS Nunes Filho Debates contemporâneos sobre Educação para a sexualidade, 261-275, 2017 | 1 | 2017 |
| Latin America and cancer clinical trials: Underrepresented region with significant growth potential. PRS Nunes Filho, P Brandalise, GS Kannan, D Gandia, MII Berraondo, ... Journal of Clinical Oncology 42 (16_suppl), e23038-e23038, 2024 | | 2024 |
| Molecular predictors and mechanisms of immune checkpoint inhibitor-induced myocarditis: A case-control study with translational correlates. SA Pang, M Flores Molina, P Thébault, Y Zheng, H Chou, C Goncalves, ... Journal of Clinical Oncology 42 (16_suppl), 12031-12031, 2024 | | 2024 |
| 1250 Molecular predictors and mechanisms of immune checkpoint inhibitor-induced myocarditis: a case-control study with translational correlates SA Pang, MF Molina, P Thébault, H Chou, C Goncalves, P Nunes Filho, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Global Epidemiological Profile of EGFR Mutation in NSCLC: Systematic Review Protocol MS Rocha, J Giacomazzi, TF Rebelatto, G Gossling, G Werutsky, ... OSF, 2023 | | 2023 |
| Abstract OT-10-01: A study to observe patients characteristics, treatment patterns and outcomes in patients with newly diagnosed breast cancer in Latin America-LATINA breast … G Werutsky, C Villareal-Garza, H Gomez, JM Donaire, J Bines, L Fein, ... Cancer Research 81 (4_Supplement), OT-10-01-OT-10-01, 2021 | | 2021 |
